Imaging services firm Diagnostic Health Services of Dallas has engaged Prudential Securities to help the company explore “various alternatives to maximize DHS shareholder value.” The company did not specify what those alternatives might be, but
Imaging services firm Diagnostic Health Services of Dallas has engaged Prudential Securities to help the company explore various alternatives to maximize DHS shareholder value. The company did not specify what those alternatives might be, but they could include either acquisitions or a merger with another firm.
Any acquisitions could be complicated by the recent decline in Diagnostic Healths share price, however. The plunge of the stock market has cut the value of the companys stock in half, with DHS shares falling from around $10 a share in July to about $4.50 in mid-September. Shares of the firm were trading as high as $13 a share in late March. The lower value of DHS shares would make it more difficult to use stock as an acquisition vehicle.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.